Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands.

Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands.

Item
http://www.wikidata.org/entity/Q34400595
Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challengesSafe and effective pharmacotherapy in infants and preschool children: importance of formulation aspectsImproved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study.Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine.Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries.Psychostimulant prescription for ADHD in new South Wales: a longitudinal perspective.Early discontinuation of attention-deficit/hyperactivity disorder drug treatment: a Danish nationwide drug utilization study.Comorbidity and Factors Affecting Treatment Non-Persistence in ADHD.A nationwide study of attention-deficit/hyperactivity disorder drug use among adults in Iceland 2003-2012.Optimising treatment strategies for ADHD in adolescence to minimise 'lost in transition' to adulthood.Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder.
P2860

Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands.

Item
http://www.wikidata.org/entity/Q34400595
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Less discontinuation of ADHD d ...... f 45 years in the Netherlands.
@ast
Less discontinuation of ADHD d ...... f 45 years in the Netherlands.
@en
Less discontinuation of ADHD d ...... f 45 years in the Netherlands.
@nl
type
label
Less discontinuation of ADHD d ...... f 45 years in the Netherlands.
@ast
Less discontinuation of ADHD d ...... f 45 years in the Netherlands.
@en
Less discontinuation of ADHD d ...... f 45 years in the Netherlands.
@nl
prefLabel
Less discontinuation of ADHD d ...... f 45 years in the Netherlands.
@ast
Less discontinuation of ADHD d ...... f 45 years in the Netherlands.
@en
Less discontinuation of ADHD d ...... f 45 years in the Netherlands.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Less discontinuation of ADHD d ...... f 45 years in the Netherlands.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P932